Verweij, Lotte
Oesch, Saskia
Naef, Rahel
Funding for this research was provided by:
Swiss National Science Fund (33IC30_198778/1)
Article History
Received: 3 April 2023
Accepted: 6 November 2023
First Online: 1 December 2023
Declarations
:
: The FICUS trial, including the current mixed methods contextual analysis, has been approved by the responsible Swiss Cantonal Ethics committee of Zurich, BASEC ID 2021–02300, approval on 28 January 2022. Key clinical partners were informed about the purpose of this study both orally and in writing. The return of the questionnaire was considered as informed consent, and a written informed consent was signed prior to the group interviews by each participant. Relevant national and international data protection regulation were respected in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.